AMI’s Patient Outcomes ... are Second to None

AMI is rigorous in subjecting all of it new products and programs to statistical analysis.  Our outcomes are measured against the standard benchmarks used in managed care.  To date, this program has:

• Reduced pharmaceutical usage in the managed group by 20%, while the unmanaged control group has increased 23% in the same geography, product and timeframe.
• Reduced in-patient utilization in the managed group by 11%, while the unmanaged control group have increased by 13%.